Diabeter

PRESS RELEASE

Patient outcomes leading in innovative diabetes-care

Nijkerk/Rotterdam, 11 May 2017 – Diabeter, a Dutch clinic network specialized in the treatment of type 1 diabetes in children and young adults, has won the Value-Based Health Care Prize 2017, an initiative by Value-Based Healthcare Center Europe. This is a recognition for the patient value-oriented approach Diabeter pursued ever since its creation in 2006. The VBHC Prize was awarded by the founder of Value-Based Healthcare, Harvard Professor Michael Porter.

Diabeter delivers comprehensive and individualized care focusing on e-health, diabetes technology  and self-care support. Diabeter was awarded the VBHC Prize 2017 for exemplifying high patient engagement, excellent clinical outcomes and strong progress in all the aspects of Professor Porter’s Value Agenda. Not only focusing on the Dutch market, Diabeter uses an extensive international collaboration network to bring the model to other countries which was highly recognized by the jury.

Video: Dr Veeze and Dr Aanstoot, founders of Diabeter, receive the Value-Based Healthcare prize 2017 from prof Porter, inventor of this ground-breaking methodology to work towards qualitative and affordable health care. 

The VBHC Prize rewards those projects that have adopted a fundamentally new line of thinking in creating excellent patient value in terms of real outcomes, real connections, and one common language. Each year, one excellent initiative is awarded the VBHC Prize, a prestigious award that boosts this initiative, and all applicants,in many ways. The VBHC Prize winner is selected by a renowned jury, and awarded by honorary chairman Harvard Professor Michael Porter, a world-leading authority on VBHC thinking.

"This is recognition of the fact that we link excellent clinical outcomes to acceptable costs, innovative patient-friendly processes and high-quality integrated care. Very motivated by this prize, the team of Diabeter is strengthened and will work even more intensively with driving value for our patients!”, said co-founder and director Dr. Aanstoot.

In April 2015, Medtronic acquired the Diabeter clinics. While keeping clinical decision making at Diabeter fully independent, Medtronic contributes to further advancing  value-based healthcare and integrated care models for diabetes patients in the Netherlands and around the world.

Read more:

• Value-based healthcare in type 1 diabetes

For questions, more information or additional footage please contact Marieke Moerman, communications officer, Tel. 088-2807275, email: communicatie@diabeter.nl

Diabeter is a Dutch, independent chain of clinics, specialized in the treatment of type 1 diabetes in children and adolescents. Currently, over 2000 patients are treated in the five locations of Diabeter in Rotterdam, Deventer, Veldhoven, Groningen and Schiphol Airport. Primary aim is to decrease the burden of type 1 patients , helping them to achieve better outcomes and live better lives with less complications. Diabeter is an EU ' Center of Reference ',  and is involved in scientific research to improve treatment,  reduce complications and to develop the final cure for diabetes. Diabeter works according to the principles of Value-based Healthcare, focused on maximizing the value of patient care.

Phone: 088-280 7277 / E-mail: info@diabeter.nl / www.diabeter.nl